MAPT and tauopathy: Although these double-transgenic AD mouse models, with only APP and PS1 mutation, are not exact replicable models of tauopathy, they have the potential to exhibit hyperphosphorylated tau as punctuate deposits and neurofibrillary changes [62, 63].